Clinical Trial Update: Voriconazole as Prophylactic Therapy in Lung Transplant Recipients [Phase 4]

View source ↗

Summary

This update reports termination of a Phase 4 trial evaluating voriconazole as infection prophylaxis in lung transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infectious Disease

Drugs mentioned

• VORICONAZOLE (Voriconazole)

Snippet

Sponsor: University of Chicago | Conditions: Infection | Phase 4 | Status: TERMINATED